Congratulations Anja Lindén!

Apr 26, 2024
1 min read

Updated: May 7, 2024

Our site investigator, Dr. Anja Lindén, has successfully defended her thesis titled 'Optimizing fluid therapy in the hemodynamically unstable patient'. Dr. Lindén's thesis work has primarily focused on the REDUSE project and has significantly contributed to the realization of the REDUSE trial.

Recent Posts

See All

REDUSE hits 50% of patient recruitment target

(June 15) Last month, the REDUSE trial passed a significant milestone by reaching 50% of its target for patient inclusion. This major threshold is an exciting development, as it reflects the interest

Patient recruitment for REDUSE begins in Tampere, Finland

(May 25) Tammerfors University Hospital (Tays) in Tampere, Finland, became the second international site to commence patient recruitment for the REDUSE study. This exciting development comes just seve

Thesis defended by another REDUSE team member, Linn Hemberg

(March 31) Linn Hemberg, an environmental science researcher in perioperative and intensive care, defended her thesis, "Critical Care, Critical Emissions: Applying life cycle assessment on intensive a

Comments